Palisade Bio Inc (PALI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2017 | 12-2016 | 09-2016 | 06-2016 | 03-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -7,567 | -21,075 | -15,679 | -10,458 | -6,606 |
| Depreciation Amortization | 160 | 685 | 559 | 381 | 275 |
| Accounts receivable | -4 | 27 | 25 | 32 | -2 |
| Other Working Capital | -768 | 1,511 | 470 | 1,020 | 1,372 |
| Other Operating Activity | 3,744 | 3,235 | 3,090 | 1,965 | 1,473 |
| Operating Cash Flow | $-4,436 | $-15,616 | $-11,536 | $-7,060 | $-3,488 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | 2,518 | 7,518 | 7,518 | 7,518 |
| PPE Investments | N/A | -98 | -98 | -98 | -15 |
| Other Investing Activity | 0 | -63 | -30 | -30 | -13 |
| Investing Cash Flow | $N/A | $2,356 | $7,389 | $7,389 | $7,490 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | 314 | 314 | N/A | N/A |
| Debt Repayment | -1,223 | -4,570 | -3,382 | -2,226 | -1,097 |
| Common Stock Issued | 2,250 | 28,119 | 8,174 | 8,309 | N/A |
| Other Financing Activity | -106 | -124 | 0 | 0 | 0 |
| Financing Cash Flow | $922 | $23,739 | $5,105 | $6,083 | $-1,097 |
| Exchange Rate Effect | 0 | -1 | 1 | 0 | -1 |
| Beginning Cash Position | 15,195 | 4,717 | 4,717 | 4,717 | 4,717 |
| End Cash Position | 11,681 | 15,195 | 5,676 | 11,129 | 7,621 |
| Net Cash Flow | $-3,515 | $10,478 | $960 | $6,412 | $2,904 |
| Free Cash Flow | |||||
| Operating Cash Flow | -4,436 | -15,616 | -11,536 | -7,060 | -3,488 |
| Capital Expenditure | N/A | -98 | -98 | -98 | -15 |
| Free Cash Flow | -4,436 | -15,714 | -11,634 | -7,158 | -3,503 |